RE:RE:RE:RE:SPAC/SPCX/ETF'sYes there is stuff that is not clear and shareholders are getting screwed. But lets take a look at the share numbers. With a 10m float If the company had any future this is nothing worth waisting time for the Thomsons.
They have money it's not in their advantage to fight about 10milion shares. They could just offer 10$ per share and most of the people will take it without hesitation.
The problem seems to be that they don't have anything, the science is not there anymore...scientinst that probably knew what they were doing left and that forced them to sell to kendrion.
I just hope that we as shareholder can recoup some of our money, and hope Thomsons take a look and at least try hard to get it done. 10m Float is small and for a company on NASDAQ nothing... This can easy be bought on some good results and everybody would be happy.
stockbuphoon wrote: Fill you boots, my friend. I wish you luck but I see recent moves by management as strictly moves wanted by Thomson to devalue the company to zero as they have the IP. It's a little too convenient that they give away Ryplazim 2 weeks before approval and then shutdown 2 human trials for 4050 4 days before PDUFA date. If that is not intentional, I am not sure what is. They didn't release CRL letter for a year and it's all of a sudden important to suggest that 2 big indications have been dropped? Yet, the 4050 phase 1 MAD trials go on for another 7 months? Does no one else sense another debacle here at former house of PLI?
inventors wrote: Ask Cantor Friz....last partner makes the rules....and their money helpped to bring us to this point,,,,,,
OR existing shareholders would have got zero...bancr't...?
I am still holding a pinch of leftovers, but bought in on some of the dips.
Today is like....pli @ 0.07/0.15/0.25...?
Load up man....lol.